Novo Nordisk, the maker of Wegovy, has initiated a global hiring freeze for non-critical roles amid increasing competition and pressure from Eli Lilly. This decision follows a profit warning that led to a significant drop in market value and the appointment of a new CEO, Mike Doustdar, who is considering cost-saving measures, including potential layoffs.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RsJVMF5
via IFTTT
No comments:
Post a Comment